logo
  • Home
  • News
Menu

Why BioNTech Rose as Much as 5% Today

Home / Stock Analysis / Why BioNTech Rose as Much as 5% Today
Article feature image

Why BioNTech Rose as Much as 5% Today

26 Jul Stock Analysis

What happened
Coronavirus stock BioNTech(NASDAQ:BNTX) was a winner on Monday. Shares of the German biotech, famous for being the co-developer of the BNT162b2 COVID-19 vaccine, peaked at a gain of over 5% on the day before settling down to a 1.5% increase.
…

Click here to view the original article.

Tags:
Global, Motley Fool
Facebook Google+ Twitter Pinterest
  Previous
Next  

Related Posts

1585186710114.jpeg
+

Genome & Company (KOSDAQ:314130) Stock Catapults 39% Though Its Price And Business Still Lag The Industry

22 Jan Stock Analysis
1756211648508.jpeg
+

Is Exxon Mobil (XOM) Still Attractive After Its Recent Share Price Strength?

22 Jan Stock Analysis

recent post

  • crypto_regulation_4db988cc1f.jpg

    PwC Says Crypto Regulation Now Powers

    Jan 22 2026
  • FSN5S6KEORK24JFJRETMG6GJIM.jpg

    Building a lazy ETF portfolio in

    Jan 22 2026
  • 1585186710114.jpeg

    Genome & Company (KOSDAQ:314130) Stock Catapults

    Jan 22 2026
  • Ben-Zhou-Co-Founder-and-CEO-Bybit-1.jpeg

    TradFi firms are increasingly warming to

    Jan 22 2026
  • 1756211648508.jpeg

    Is Exxon Mobil (XOM) Still Attractive

    Jan 22 2026

Categories

  • Business
  • Crypto News
  • Investing Strategy
  • People
  • Stock Analysis

©2019.  All Rights Reserved.